GLS and cancer: Thus, shifts in glutamine nitrogen metabolism that promote nucleotide biosynthesis via the increased expression of PPAT while suppressing the GLS response, as demonstrated in SCLC, are important in cancer malignancy, and may be a potential therapeutic target for pancreatic cancer in a glutamine-limited environment.